Navigation Links
Former Biolase CEO & EVP Launch Technology4Medicine
Date:2/21/2008

Lasers4Dentistry Division Focused on Dental Laser Market

SAN CLEMENTE, Calif., Feb. 21 /PRNewswire/ -- The former senior executives of Biolase Technologies, Inc. (Nasdaq: BLTI) announced the formation of a new company, Technology4Medicine, LLC, with a dental laser division, Lasers4Dentistry, and a laser therapy division, Technology4Therapy. Jeffrey W. Jones, the former President and CEO of Biolase, and Keith G. Bateman, Biolase's former Executive Vice President, formed Technology4Medicine to address the advanced technological, clinical, training and business needs of the dental, medical, veterinary and physiotherapy communities.

"While developing the dental laser industry and growing Biolase from approximately $1 million to $70 million in sales and 70-80% market share, we gained extensive experience and a deep understanding of the unique clinical and business needs of the dental community," commented Jones, Technology4Medicine CEO. "Dentists face unique challenges, both clinical and financial, and our combined 40 plus years of executive and field experience in the technology, medical and dental laser markets positions Technology4Medicine and its divisions to help dentists and other medical practitioners to achieve their goals."

"Over the coming weeks and months Technology4Medicine will be introducing a broad range of advanced technology and laser based products focused on enhancing efficiency, the quality of clinical care, the patient experience and the bottom line of dental practices," added Bateman, Technology4Medicine President.

"Laser therapy has long been established and accepted as standard of care internationally. Recently the technology and clinical applications have made significant breakthroughs
'/>"/>

SOURCE Technology4Medicine, LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Nyer Medical Group Completes Acquisition of Minority Interest in Pharmacy Chain Subsidiary; Former Minority Shareholders Invest in Nyer Medical Group and Sign 3-Year Employment Agreements
2. OrthoSynetics(TM) Applauds SEC Suit Against Former Company Management
3. Local VA Performers Hold February 15 Benefit to Reduce $10,000 in Medical Bills for Former VCU Student Kellie Brown
4. Herley Industries Announces the Passing of Its Former President
5. Former Navy Surgeon General Is Among Three New Accomplished TriWest Advisory Board Members
6. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, and Dr. Barry Karlin, Nations #1 Drug Treatment Provider, to Spearhead Drug Treatment WVA Advocacy Day Feb 13-14; 142,000 Need, Dont Get Treatment in State
7. Formerly Conjoined Twins Leave Packard Childrens Hospital; Heading Home to Costa Rica
8. Former substance abusers rarely relapse after organ transplantation
9. Pentec Health Taps Former Cardinal Health Executive Joseph Cosgrove as Chief Executive Officer
10. Vital Training Tools Elevate New Pharmaceutical Sales Reps into Top Performers During Critical First Year
11. Former Actor has Mobility Restored With Power Wheelchair Gift From The Scooter Store
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...LEM, N.C. A study out of Wake Forest University B...doctors are correctly identifying patients who are... haven,t yet confirmed it. , The study used data...ents with heart attack symptoms who were admitted ...ing U.S. centers. , The findings were released ...
(Date:7/23/2008)...red Problem For 10+ Years Even Though Some Kilns E... on Cement Kilns in AL, CA, IA,IL, MD, MI, MT, NY...wswire-USNewswire/ -- For more than a decade,after...ion from cement,kilns across the nation, the U.S. ...ake action. Now, a new study from Earthjustice and...
(Date:7/23/2008)...n DC - July 23, 2008) Biodiversity has long been r...l-being. Humans rely on healthy ecosystems to pro...s understood is the connection between disease and...d animals found in a geographic region). Recent s...rotect us against diseases such as Lyme disease an...
(Date:7/23/2008)...S, July 23 /PRNewswire/ -- Mercy Health Plans, the...y founded in 1994 by the,Sisters of Mercy Health S...s Medicare Advantage plans to: Mercy MedicareAdvan...t. Louis, Illinois and Southwest Missouri,previou...ierPlus Options,St. John,s PremierPlus and St. Jo...
Breaking Medicine News(10 mins):Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 3Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 4Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 5Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 6Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 7Health News:Could preserving biodiversity reduce disease? 2
...tudy suggests that eating more fiber and fruit eac...he study is based on the results of examining the ...ht or obese adults. The study found that normal w...dietary fiber and 43 percent more complex carbohyd...
...n Saturday reported a new outbreak of bird flu amo... Xinjiang.// The national avian influenza laborat...he H5N1 avian influenza virus, stemming from an ou...4 near the town of Aksu, the agriculture ministry ...
...Food and Drug Administration (FDA) gave approval t...e matchstick sized contraceptive is implanted bene...regnancy for three year after which it may be repl...Implanon said that the implant would release a low...
... (tigecycline)is a new, expanded broad-spectrum IV...a wide range of infections including those caused ...llin-resistant Staphylococcus aureus (MRSA). It wi...y of this new antibiotic comes at a time when the ...
Other Medicine News:Health News:Broad Spectrum Antibiotic Available for Antibiotic Resistant Bacteria 2
(Date:7/22/2008)... the Importance to Patients of Passing a ...HMOND, Va., July 22 /- Insm... biologics and biopharmaceuticals, today,announced...resent at a,Congressional briefing on Friday, July...tablishing an approval pathway for follow-on,biolo...
(Date:7/22/2008)...y 22 /- NicOx S.A.,(Euronex...completed the,enrollment of 417 osteoarthritis (OA...nical pharmacology studies in the United States, i...trials are designed to assess the,blood pressure p...and,naproxen, using the Ambulatory Blood Pressure ...
(Date:7/21/2008)...-- The University of Oxford Clinical Trial,Service...osed that the,hypothesis-generating results of the...wing the combined cancer results from the SHARP an... the overall findings to,the relevant regulatory a...s., The two hypothesis-testing trials (SHARP and ...
(Date:7/21/2008)... clinicians identify risk in patients, includin...tin therapy, BIRMINGHAM, Ala., July 21 /PRNewswir...ch, researchers have identified a link between,adi...ation could help,physicians trying to pinpoint the...-lowering treatments in at-risk patients., The as...
Breaking Medicine Technology:Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe 2Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe 3VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 2VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 3Sex is thirst quenching for female beetles 165 1Sex is thirst quenching for female beetles 165 2Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns Australia 213 1Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns Australia 213 2KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates 210 1KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates 210 2Advanced Life Sciences Announces ALS 357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 149 1Advanced Life Sciences Announces ALS 357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 149 2Advanced Life Sciences Announces ALS 357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 149 3Advanced Life Sciences Announces ALS 357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 149 4
...imaging technique suggests how lithium works as a,...ientists at UCLA have shown,that lithium, long the...s the amount of gray matter in the brains of patie... in the July issue of the journal,Biological Psych...e Bearden, a clinical neuropsychologist and assist...
...May Provide Cancer Patients With Improved Potentia... 16, 2007 /PRNewswire/ -- Insert,Therapeutics, Inc...ch Corporation announced today its novel delivery ...poster presentation at,the 2007 American Associati...articular, this poster includes new research findi...
Other Medicine Technology:UCLA: Lithium Builds Gray Matter in Bipolar Brains, UCLA Study,Shows 2UCLA: Lithium Builds Gray Matter in Bipolar Brains, UCLA Study,Shows 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 2Poster on Cyclosert Drug Delivery Presented at AACR Meeting 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 4
Operating Microscope with excellent maneuverability. Konan made it compact and light weight maintaining high quality. Easy switchover from straight to oblique by simply changing the adapter. Konan's
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure.
With side bite Instrument recommended to catch the polypropylene thread in the nose.
Instrument necessary for insertion of Ritleng Bicanaliculus systems and of Self-Threading Monoka systems.
Medicine Products: